Company Filing History:
Years Active: 1992-1995
Title: Tomio Araki: Innovator in Medicinal Chemistry
Introduction
Tomio Araki is a distinguished inventor based in Tokyo, Japan. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on diurea derivatives. With a total of four patents to his name, Araki's research has the potential to impact the pharmaceutical industry positively.
Latest Patents
Araki's latest patents focus on diurea derivatives that are useful as medicaments. These derivatives can be represented by a specific general formula, which includes various alkyl and cycloalkyl groups. Notable examples of these derivatives include 1,3-bis[[1-cycloheptyl-3-(3-pyridyl)ureido]-methyl]benzene, 1,3-bis[[1-cycloheptyl-3-(2-pyridyl)ureido]-methyl]benzene, and 1,3-bis[[1-cycloheptyl-3-(4-pyridyl)ureido]-methyl]benzene. These compounds are designed to inhibit acyl-coenzyme A cholesterol acyltransferase (ACAT enzyme), which helps control the accumulation of cholesterol esters in the arterial walls of blood vessels.
Career Highlights
Tomio Araki is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he continues to advance his research in medicinal chemistry. His work has garnered attention for its potential therapeutic applications, particularly in managing cholesterol levels and related health issues.
Collaborations
Araki has collaborated with notable colleagues, including Noriki Ito and Tomoyuki Yasunaga. These partnerships have contributed to the development and refinement of his innovative medicinal compounds.
Conclusion
Tomio Araki's contributions to the field of medicinal chemistry through his patents on diurea derivatives highlight his role as a key innovator. His work not only showcases his expertise but also holds promise for future advancements in pharmaceutical treatments.